DDW_Benchling & BPS_Logo_400px copy
CGT_webinar_speaker_images_200px_New copy
Cell and gene therapies are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will offer innovation for the future. 
In this webinar, you will hear from CBO/CDO of Adthera Bio, Stuart Curbishley, Chief Executive Officer of Cell & Gene Therapy Catapult, Matthew Durdy, Scientific Solutions Consultant of Benchling, Brian Fan, and Founder and CEO of Dark Horse Consulting, Anthony Davies.
The event will cover aspects affecting growth of the CGT market, including how manufacturing technologies are enabling drug development, what these therapies mean for the healthcare market, and the opportunities for developers.  
What you will learn: 
  • The opportunities cell and gene therapies offer drug discovery and development 
  • How to sustain and maximise market growth  
  • The challenges facing cell and gene therapies  
  • Where are the opportunities for innovation? (autologous therapies/solid tumours/ indications outside of oncology?)  
An audience Q&A session with the presenter follows the webinar presentation.

Watch the webinar on-demand now!

Watch the Webinar